#WorldLungCancerDay: The importance of early detection and how AI can help.

#LungCancer continues to be the leading cause of cancer-related deaths in the world and the second most common cancer worldwide. Today’s observation of #WorldLungCancerDay provides an important opportunity to bring awareness to the key risk factors, as well as the importance of early detection.

One of the biggest challenges in the diagnosis of lung cancer is determining the malignancy of a lung nodule and that’s why I’m excited about GE Healthcare’s collaboration with Optellum to help streamline clinician workflows so healthcare providers can take the right action at the right time and help improve patient outcomes.

Suspicious lesions may be benign or cancerous, but most incidentally detected pulmonary nodules present an indeterminate cancer risk that is incredibly challenging for clinicians to diagnose and manage. Optellum’s Virtual Nodule Clinic identifies and scores the probability of malignancy in a lung nodule, which is key to determining whether biopsy is necessary as well as accelerating diagnosis.

Collaborations pairing healthcare expertise with breakthrough tech to accelerate the journey to better patient care is the future of precision medicine. By partnering with Optellum to use AI in conjunction with imaging technologies, like low-dose CT screening, to promote early diagnosis and treatment of lung cancer we can help clinicians identify lung cancer earlier and help design personalized treatments for it.

Could not be more excited about what’s ahead!